BRCA1 and prostate carcinoma: BRCA1 mutation has been recently reported to promote migration and invasion by interacting with Ezrin-Radixin-Moesin proteins in the plasma membrane.26 β-hCG has also been demonstrated to promote metastasis in prostate cancer cells.